As the global life sciences community gathers in Boston for the Immuno-Oncology 360° (IO360°) conference, TCR Solutions, a UK-based clinical research organisation (CRO), is proud to be part of the conversation driving innovation in cancer research and clinical development across the UK, Europe and the US.
Boston remains a global hub for immuno-oncology, cell therapy, and precision medicine, and our CEO’s attendance at this year’s event underscores our commitment to supporting innovative biotech companies with speed, quality, and regulatory confidence.
A CRO Partner for Boston’s Biotech and Immuno-Oncology Innovators
TCR Solutions is a clinical research organisation (CRO) supporting emerging and established biotech companies delivering complex oncology studies across the UK, Europe and the US. As a UK CRO with extensive international reach, we work as an extension of sponsor teams to help move assets from discovery into the clinic.
We provide flexible support across early-phase clinical trials, data management, biostatistics, and regulatory affairs. By combining scientific expertise with operational excellence, we help our clients design and execute studies that meet the highest standards of clinical integrity while maintaining agility in a competitive research landscape.
Delivering Excellence in Oncology Clinical Research
TCR Solutions offers a full suite of clinical research services designed to support biotech companies at every stage of development:
- Clinical Operations: Comprehensive trial management from site selection to closeout, ensuring timelines and budgets are met
- Data Management & Biostatistics: Robust data solutions that transform complex clinical data into actionable insights
- Regulatory Affairs: Strategic guidance to navigate global regulatory requirements and accelerate approvals
- Quality Assurance: Rigorous oversight to maintain compliance and uphold the highest ethical standards
Our team’s deep understanding of oncology and immunotherapy trials allows us to anticipate challenges and deliver solutions that drive progress for biotech sponsors worldwide.
Driving the Future of Immuno-Oncology
The IO360° conference brings together leaders from across the immuno-oncology landscape to share insights, foster collaboration, and shape the future of cancer treatment. For TCR Solutions, it’s an opportunity to strengthen relationships with Boston’s biotech community and explore new ways to support faster start-up, efficient trial delivery, and high-quality outputs across oncology programmes.
With experience delivering clinical trials in the UK and Europe, we bring a global perspective to oncology research — helping sponsors navigate regulatory requirements across multiple jurisdictions while maintaining the highest standards of quality.
Let’s Meet at IO360°
If you’re attending IO360° in Boston and planning an upcoming immuno-oncology or oncology clinical trial, we’d welcome the chance to connect. Get in touch to schedule a meeting and discuss how TCR Solutions can support your study from protocol through delivery.
Contact us or visit www.tcr-solutions.com.